Macopharma
Manufacturer and developer of integrated blood‑processing solutions including single‑use disposables, equipment, software and processing guidelines. Emphasis on product safety, regulatory compliance, R&D-driven innovation and sustainability to support blood component collection, processing, storage and distribution worldwide.
Industries
Nr. of Employees
Very Large (1000+)
Macopharma
200 Chaussée Fernand Forest, 59200 Tourcoing, France (Headquarters)
Products
Blood collection and processing disposable systems
Medical‑grade blood bags, collection sets, transfer and pooling kits for collection, separation, transfer and storage of blood components.
Phlebotomy bags
Dedicated collection bags and kits intended for therapeutic phlebotomy and related clinical collection.
Equipment for sealing, illumination and automated processing
Benchtop sealing devices, illumination modules and automated processing machines for sealing, pathogen inactivation illumination and component processing.
High‑frequency sealer for EVA and PVC tubes
Sealers designed for welding EVA and PVC tubing used in biobanking and collection workflows.
Leukodepletion filter systems
In‑line and dockable filtration consumables for leukoreduction of red cells, platelets and plasma.
Cryopreservation and biobanking consumables
EVA cryobags, tissue storage pots and kits for cell and tissue freezing and long‑term storage.
Blood collection and processing disposable systems
Medical‑grade blood bags, collection sets, transfer and pooling kits for collection, separation, transfer and storage of blood components.
Phlebotomy bags
Dedicated collection bags and kits intended for therapeutic phlebotomy and related clinical collection.
Equipment for sealing, illumination and automated processing
Benchtop sealing devices, illumination modules and automated processing machines for sealing, pathogen inactivation illumination and component processing.
High‑frequency sealer for EVA and PVC tubes
Sealers designed for welding EVA and PVC tubing used in biobanking and collection workflows.
Leukodepletion filter systems
In‑line and dockable filtration consumables for leukoreduction of red cells, platelets and plasma.
Cryopreservation and biobanking consumables
EVA cryobags, tissue storage pots and kits for cell and tissue freezing and long‑term storage.
Services
Incident monitoring, vigilance reporting and clinical follow‑up for marketed blood‑processing products.
Business continuity planning, risk assessments and supply‑chain resilience activities aligned with ISO 22301.
Incident monitoring, vigilance reporting and clinical follow‑up for marketed blood‑processing products.
Business continuity planning, risk assessments and supply‑chain resilience activities aligned with ISO 22301.
Expertise Areas
- Blood processing and component manufacturing
- Leukoreduction and filtration technologies
- Pathogen inactivation for blood products
- Platelet processing and pooling workflows
Key Technologies
- Single‑use blood bag systems
- Sterile connection devices for pooling
- In‑line leukodepletion filters
- Pathogen inactivation illumination systems (UV/photochemical)
News & Updates
Company participation and scientific presence at GCIAMT 2025.
Article discussing long‑term perspectives for the blood industry.
Publication of corporate sustainability and CSRD reports outlining CSR ambitions and metrics.
Study evaluating effects of sampling methods on hemolysis measurements.
Comparative study analyzing additive solutions and their impact on red blood cell quality.
First US Evaluation of Buffy Coat‑derived Platelets using Whole Blood Processing with a 24‑Hour Hold
Evaluation study of buffy coat‑derived platelet preparation and holding conditions in a US context.
Company participation and scientific presence at GCIAMT 2025.
Article discussing long‑term perspectives for the blood industry.
Publication of corporate sustainability and CSRD reports outlining CSR ambitions and metrics.
Study evaluating effects of sampling methods on hemolysis measurements.
Comparative study analyzing additive solutions and their impact on red blood cell quality.
First US Evaluation of Buffy Coat‑derived Platelets using Whole Blood Processing with a 24‑Hour Hold
Evaluation study of buffy coat‑derived platelet preparation and holding conditions in a US context.